XML 63 R48.htm IDEA: XBRL DOCUMENT v3.24.0.1
Schedule II - Condensed Financial Information of Parent Company (Tables)
12 Months Ended
Dec. 31, 2023
Notes Tables  
Condensed Balance Sheet [Table Text Block]
  

December 31, 2023

  

December 31, 2022

 

Assets

        

Investments:

        

Fixed maturity securities available for sale, at fair value (amortized cost: $51,946 in 2023, $51,993 in 2022)

 $48,626  $45,511 

Equity securities, at fair value: (cost: $1,725 in 2023, $1,725 in 2022)

  1,835   1,626 

Equity method investment

  2,617    

Total investments

  53,078   47,137 

Cash and cash equivalents

  314   781 

Accrued investment income

  345   320 

Prepaid expenses and other assets

  3,780   2,267 

Receivables from subsidiaries

  51,967   3,689 

Note receivable from subsidiary

  15,000    

Investment in subsidiaries

  530,690   405,525 

Total assets

 $655,174  $459,719 

Liabilities and Stockholders' equity

        

Liabilities:

        

Accounts payable and other liabilities

 $10,120  $7,359 

Payables to subsidiaries

  157,404   57,324 

Federal income tax payable

  16,398   10,282 

Total liabilities

  183,922   74,965 

Stockholders' equity:

        

Common stock, $0.0001 par value, 500,000,000 shares authorized, 24,772,987 and 25,027,467 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively

  3   3 

Additional paid‑in capital

  350,597   333,557 

Accumulated other comprehensive income (loss)

  (23,991)  (36,514)

Retained earnings

  144,643   87,708 

Total stockholders' equity

  471,252   384,754 

Total liabilities and stockholders' equity

 $655,174  $459,719 
Condensed Income Statement [Table Text Block]
   

Year Ended December 31,

 
   

2023

   

2022

   

2021

 

Revenues:

                       

Net investment income

  $ 1,699     $ 1,048     $ 555  

Net realized and unrealized gains (losses) on investments

    (209 )     (320 )     217  

Total revenues

    1,490       728       772  

Expenses:

                       

Other operating expenses

    39,347       33,292       19,480  

Loss before income taxes

    (37,857 )     (32,564 )     (18,708 )

Income tax (benefit) expense

    (7,953 )     (8,464 )     11,039  

Loss before equity in net income of subsidiaries

    (29,904 )     (24,100 )     (29,747 )

Equity in net income of subsidiaries

    109,105       76,270       75,594  

Net income

  $ 79,201     $ 52,170     $ 45,847  

Other comprehensive income:

                       

Net unrealized (losses) gains on securities available for sale

    (2,505 )     (3,997 )     580  

Equity in other comprehensive income (loss) of subsidiaries, net of taxes

    15,029       (37,830 )     (8,514 )

Total comprehensive income

  $ 91,725     $ 10,343     $ 37,913  
Condensed Cash Flow Statement [Table Text Block]
   

Year Ended December 31,

 
   

2023

   

2022

   

2021

 

Operating activities

                       

Net income

  $ 79,201     $ 52,170     $ 45,847  

Adjustments to reconcile net income to net cash provided by operating activities:

                       

Equity in undistributed earnings of subsidiaries

    (109,105 )     (76,270 )     (75,594 )

Stock-based compensation expense

    10,426       8,820       4,755  

Net realized and unrealized (losses) gains on investments

    209       320       (217 )

Amortization of premium on fixed maturity securities

    189       347       443  

Deferred income tax expense

    2,787       7,210       634  

Changes in operating assets and liabilities:

    37,777       36,449       13,596  

Net cash provided by (used in) operating activities

    21,484       29,046       (10,536 )

Investing activities

                       

Purchases of fixed maturity securities

    (11,045 )     (9,807 )     (2,177 )

Sales and maturities of fixed maturity securities

    9,232       8,488       11,396  

Cash paid to subsidiaries

                (15,595 )

Cash received from subsidiaries

                27,100  

Net cash (used in) provided by investing activities

    (1,813 )     (1,319 )     20,724  

Financing activities

                       

Proceeds from common stock issued via equity incentive plans

    2,038       3,032       2,811  

Policyholder contribution to surplus

    90              

Repurchase of common stock

    (22,266 )     (34,415 )     (15,852 )

Net cash used in financing activities

    (20,138 )     (31,383 )     (13,041 )

Net decrease in cash and cash equivalents

    (467 )     (3,656 )     (2,853 )

Cash and cash equivalents at beginning of period

    781       4,437       7,290  

Cash and cash equivalents at end of period

  $ 314     $ 781     $ 4,437  

Supplementary cash flow information:

                       

Cash paid for income taxes

  $ 21,124     $ 18,890     $ 2,104  

Cash paid for interest

  $ 3,682     $ 704     $